By the same authors

Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data

Research output: Working paperDiscussion paper

Standard

Cost per DALY averted thresholds for low- and middle-income countries : evidence from cross country data. / Ochalek, Jessica Marie; Lomas, James; Claxton, Karl Philip.

York, UK : Centre for Health Economics, University of York, 2015. p. 1-50 (CHE Research Paper; No. 122).

Research output: Working paperDiscussion paper

Harvard

Ochalek, JM, Lomas, J & Claxton, KP 2015 'Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data' CHE Research Paper, no. 122, Centre for Health Economics, University of York, York, UK, pp. 1-50.

APA

Ochalek, J. M., Lomas, J., & Claxton, K. P. (2015). Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data. (pp. 1-50). (CHE Research Paper; No. 122). York, UK: Centre for Health Economics, University of York.

Vancouver

Ochalek JM, Lomas J, Claxton KP. Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data. York, UK: Centre for Health Economics, University of York. 2015 Dec, p. 1-50. (CHE Research Paper; 122).

Author

Ochalek, Jessica Marie ; Lomas, James ; Claxton, Karl Philip. / Cost per DALY averted thresholds for low- and middle-income countries : evidence from cross country data. York, UK : Centre for Health Economics, University of York, 2015. pp. 1-50 (CHE Research Paper; 122).

Bibtex - Download

@techreport{12487fa5e63f4ac39fa403b2795065eb,
title = "Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data",
abstract = "Low- and middle-income countries (LMICs) face difficult decisions about which health care interventions are worthwhile given existing constraints on health care expenditure. Decisions require some assessment of the health opportunity costs of proposed investments, i.e., a ‘supply side’ cost-effectiveness threshold (CET) that represents the likely health effects of changes in health care expenditure. This paper provides a framework for generating country-level CETs using existing published estimates of the mortality effect of health expenditure. Two different estimation strategies are used (Bokhari et al (2007) and Moreno-Serra and Smith (2015)) and, where possible, estimation is extended to include other measures of mortality, survival and disability outcomes, reflecting the demographic and other characteristics of each LMIC.The results suggest that CETs representing likely health opportunity costs tend to be below the lower bound suggested by WHO of 1x GDP per capita. Hence, many previous and existing recommendations about which interventions are cost-effective that are based on the WHO threshold are likely to do more harm than good.",
author = "Ochalek, {Jessica Marie} and James Lomas and Claxton, {Karl Philip}",
year = "2015",
month = "12",
language = "English",
series = "CHE Research Paper",
publisher = "Centre for Health Economics, University of York",
number = "122",
pages = "1--50",
type = "WorkingPaper",
institution = "Centre for Health Economics, University of York",

}

RIS (suitable for import to EndNote) - Download

TY - UNPB

T1 - Cost per DALY averted thresholds for low- and middle-income countries

T2 - evidence from cross country data

AU - Ochalek, Jessica Marie

AU - Lomas, James

AU - Claxton, Karl Philip

PY - 2015/12

Y1 - 2015/12

N2 - Low- and middle-income countries (LMICs) face difficult decisions about which health care interventions are worthwhile given existing constraints on health care expenditure. Decisions require some assessment of the health opportunity costs of proposed investments, i.e., a ‘supply side’ cost-effectiveness threshold (CET) that represents the likely health effects of changes in health care expenditure. This paper provides a framework for generating country-level CETs using existing published estimates of the mortality effect of health expenditure. Two different estimation strategies are used (Bokhari et al (2007) and Moreno-Serra and Smith (2015)) and, where possible, estimation is extended to include other measures of mortality, survival and disability outcomes, reflecting the demographic and other characteristics of each LMIC.The results suggest that CETs representing likely health opportunity costs tend to be below the lower bound suggested by WHO of 1x GDP per capita. Hence, many previous and existing recommendations about which interventions are cost-effective that are based on the WHO threshold are likely to do more harm than good.

AB - Low- and middle-income countries (LMICs) face difficult decisions about which health care interventions are worthwhile given existing constraints on health care expenditure. Decisions require some assessment of the health opportunity costs of proposed investments, i.e., a ‘supply side’ cost-effectiveness threshold (CET) that represents the likely health effects of changes in health care expenditure. This paper provides a framework for generating country-level CETs using existing published estimates of the mortality effect of health expenditure. Two different estimation strategies are used (Bokhari et al (2007) and Moreno-Serra and Smith (2015)) and, where possible, estimation is extended to include other measures of mortality, survival and disability outcomes, reflecting the demographic and other characteristics of each LMIC.The results suggest that CETs representing likely health opportunity costs tend to be below the lower bound suggested by WHO of 1x GDP per capita. Hence, many previous and existing recommendations about which interventions are cost-effective that are based on the WHO threshold are likely to do more harm than good.

M3 - Discussion paper

T3 - CHE Research Paper

SP - 1

EP - 50

BT - Cost per DALY averted thresholds for low- and middle-income countries

PB - Centre for Health Economics, University of York

CY - York, UK

ER -